ARCHIVES

FDA Hears More Criticism On Cancer Drug Endpoints; Joint Conferences On Criteria Recommended

This article is from The Cancer Letter archive.

Vol. 15 No. 30 | July 28, 1989

Download PDF Visit The Full Archive

Related Articles

Trials Approved by NCI CTEP For the Month of January

January 27, 2012

NCI’s Drug Screen Tests 400 Agents A Week; Recompetition Of Contracts Approved

February 26, 1993

Litton Wins FCRF Research Contract, Harland Land Animal Protections

September 17, 1982

NCI Finds Physician Recommendation Drives Patient Demand For ABMT

July 19, 1996

Obituary: Ronald Herberman, 72, UPCI Founding Director

July 3, 2013

Chart of FY 1991 Budget For NCI By Mechanism

February 2, 1990